Scientists accelerate progress in preventing drug resistance in lung and pancreas cancers

(Huntsman Cancer Institute) Scientists at Huntsman Cancer Institute at the University of Utah report today the development of new models to study molecular characteristics of tumors of the lung and pancreas that are driven by mutations in a gene named NTRK1. The findings were published today in the journal Cell Reports.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news